Order in --:--:-- → ships today
CJC-1295 (no DAC) + Ipamorelin Blend
≥99.0%
GH-axis blend (GHRH analog + ghrelin agonist) · 5mg + 5mg

CJC-1295 (no DAC) + Ipamorelin Blend

CJC-1295 (no DAC) + Ipamorelin — GHRH analog and ghrelin-receptor agonist synergy blend

Verify this batchHPLC + MS

The certificate for the current lot isn't published yet. Every lot is third-party tested before it ships.

Dosage
Quantity
In stock — --:--:-- to ship today
1
$75.00
Overview

This blend combines CJC-1295 (modified GRF 1-29, no DAC) — a short-acting GHRH analog with a half-life of approximately 30 minutes — with Ipamorelin, a selective ghrelin-receptor agonist (growth hormone secretagogue). The two molecules act on parallel but distinct receptors of the somatotropic axis: CJC-1295 amplifies the GHRH signal, while Ipamorelin mimics ghrelin to trigger GH release without significantly elevating cortisol, prolactin, or ACTH. The 'no DAC' designation indicates the molecule lacks the Drug Affinity Complex, preserving the natural pulsatile GH-release pattern that is critical in many research designs.

Mol. weight3367.94 / 711.85
Purity≥99.0% each component
FormLyophilized powder
Storage−20°C, dry, dark

Questions

Each vial contains lyophilized peptide powder at the labeled dosage. No solvents, fillers, or preservatives.

Research use only. Not for human or veterinary use.